These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 13783079

  • 1. Effects of lysergic acid diethylamide, and differences between normals and schizophrenics on the Stroop Color-Word Test.
    WAPNER S, KRUS DM.
    J Neuropsychiatr; 1960; 2():76-81. PubMed ID: 13783079
    [No Abstract] [Full Text] [Related]

  • 2. Studies in the effect of lysergic acid diethylamide (LSD-25): self- and object-size perception in schizophrenics and normal adults.
    LIEBERT RS, WERNER H, WAPNER S.
    AMA Arch Neurol Psychiatry; 1958 May; 79(5):580-4. PubMed ID: 13519960
    [No Abstract] [Full Text] [Related]

  • 3. 'Schizophrenia' produced by LSD-25.
    BOLTON WB.
    Nurs Times; 1962 Jan 05; 58():22-4. PubMed ID: 13870860
    [No Abstract] [Full Text] [Related]

  • 4. Effects of LSD-25 on relatives of schizophrenic patients.
    ANASTASOPOULOS G, PHOTIADES H.
    J Ment Sci; 1962 Jan 05; 108():95-8. PubMed ID: 13861108
    [No Abstract] [Full Text] [Related]

  • 5. Human figure drawings of schizophrenic and normal adults. Changes following administration of lysergic acid.
    MACHOVER K, LIEBERT R.
    Arch Gen Psychiatry; 1960 Aug 05; 3():139-52. PubMed ID: 14419430
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Conceptual thinking in schizophrenics and their relatives.
    Phillips JE, Jacobson N, Turner WJ.
    Br J Psychiatry; 1965 Sep 05; 111(478):823-39. PubMed ID: 5824954
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Studies in the effects of lysergic acid diethylamide (LSD-25); visual perception of verticality in schizophrenic and normal adults.
    LIEBERT RS, WAPNER S, WERNER H.
    AMA Arch Neurol Psychiatry; 1957 Feb 05; 77(2):193-201. PubMed ID: 13393877
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Performance on some objective tests under LSD-25.
    BARENDREGT JT.
    Fortschr Psychosom Med; 1960 Feb 05; 1():217-9. PubMed ID: 13796717
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Potentiation of substance P by lysergic acid diethvlamide in vivo.
    KRIVOY WA.
    Br J Pharmacol Chemother; 1961 Jun 05; 16(3):253-6. PubMed ID: 13754427
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lysergic acid diethylamide tartrate (LSD-25) dosage levels, group differences and social interaction.
    Cheek FE, Holstein CM.
    J Nerv Ment Dis; 1971 Aug 05; 153(2):133-47. PubMed ID: 5572106
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A paradigm for the study of altered states of consciousness.
    Silverman J.
    Br J Psychiatry; 1968 Oct 05; 114(515):1201-18. PubMed ID: 5721937
    [No Abstract] [Full Text] [Related]

  • 20. LSD and onset of schizophrenia.
    Roy A.
    Can J Psychiatry; 1981 Feb 05; 26(1):64-5. PubMed ID: 7471035
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.